13 days ago
RVMD
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 3%
#147 out of 5286 analysts
Average Return
+21.93%
Win Rate
44%118 out of 268
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-09 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +864.38% | $22.88 | $220.65 | 2024-12-13 - 2025-12-12 | Buy |
Cidara Therapeutics IncCDTX | +811.78% | $24.28 | $221.38 | 2025-05-23 - 2026-01-06 | Buy |
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-13 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-05 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
17 days ago
CGON
23 days ago
GILD
3 months ago
ONC
4 months ago
GILD
4 months ago
CGON
4 months ago
GILD
5 months ago
CGON
5 months ago
IDYA
6 months ago
CATX
6 months ago
NRIX
6 months ago
GILD
6 months ago
ONC
3 years ago
RXDX
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revolution Medicines IncRVMD | 1 | Strong Buy | $179.00 | +13.67% | Assumes | 13 days ago |
Regeneron Pharmaceuticals IncREGN | 6 | Strong Buy | $778.00 | +26.55% | Maintains | 13 days ago |
Cg Oncology IncCGON | 8 | Strong Buy | $82.00 | +31.64% | Reiterates | 17 days ago |
Gilead Sciences IncGILD | 4 | Strong Buy | $157.00 | +16.79% | Reiterates | 23 days ago |
Beone Medicines LtdONC | 5 | Strong Buy | $413.00 | +43.44% | Reiterates | 24 days ago |
Amgen IncAMGN | 20 | Hold | $327.00 | -2.91% | Maintains | a month ago |
Agios Pharmaceuticals IncAGIO | 9 | Strong Buy | $36.00 | +22.45% | Maintains | a month ago |
Viridian Therapeutics IncVRDN | 14 | Strong Buy | $33.00 | +87.29% | Maintains | a month ago |
Ideaya Biosciences IncIDYA | 14 | Strong Buy | $60.00 | +103.60% | Maintains | 5 months ago |
Fulcrum Therapeutics IncFULC | 5 | Strong Buy | $18.00 | +160.12% | Maintains | 6 months ago |
Perspective Therapeutics IncCATX | 7 | Strong Buy | $12.00 | +204.57% | Assumes | 6 months ago |
Nurix Therapeutics IncNRIX | 12 | Strong Buy | $30.00 | +68.92% | Assumes | 6 months ago |
Xencor IncXNCR | 10 | Strong Buy | $29.00 | +144.11% | Initiates Coverage On | 6 months ago |
Nuvation Bio IncNUVB | 7 | Strong Buy | $11.00 | +130.13% | Initiates Coverage On | 6 months ago |
Nuvalent IncNUVL | 1 | Strong Buy | $140.00 | +26.82% | Initiates Coverage On | 6 months ago |
Mannkind CorpMNKD | 2 | Strong Buy | $9.00 | +138.73% | Initiates Coverage On | 6 months ago |
Bicycle Therapeutics PLCBCYC | 4 | Hold | $10.00 | +113.22% | Initiates Coverage On | 6 months ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $51.00 | +154.87% | Initiates Coverage On | 6 months ago |
Abivax SaABVX | 1 | Strong Buy | $140.00 | +5.56% | Initiates Coverage On | 6 months ago |
Exelixis IncEXEL | 11 | Hold | $50.00 | -0.95% | Downgrades | a year ago |
Cidara Therapeutics IncCDTX | 3 | Buy | $35.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 14 | Buy | $26.00 | N/A | Reiterates | a year ago |
Adc Therapeutics SaADCT | 12 | Buy | $8.00 | N/A | Reiterates | a year ago |
Inovio Pharmaceuticals IncINO | 11 | Hold | $5.00 | N/A | Reiterates | a year ago |
Jazz Pharmaceuticals PLCJAZZ | 14 | Buy | $172.00 | N/A | Maintains | a year ago |
Spruce Biosciences IncSPRB | 13 | Hold | $0.50 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 6 | Buy | $12.00 | N/A | Reiterates | a year ago |
Verastem IncVSTM | 10 | Buy | $14.00 | N/A | Maintains | a year ago |
Pacira Biosciences IncPCRX | 11 | Hold | $18.00 | N/A | Reiterates | a year ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $48.00 | N/A | Maintains | a year ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 7 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Atyr Pharma IncATYR | 7 | Buy | $16.00 | N/A | Reiterates | 2 years ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | N/A | Reiterates | 2 years ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | N/A | Downgrades | 2 years ago |
Aptose Biosciences IncAPTOF | 7 | Buy | $540.00 | N/A | Maintains | 3 years ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | 3 years ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | 3 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 4 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 4 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Iterum Therapeutics PLCITRMF | 3 | Hold | $30.00 | N/A | Downgrades | 6 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 6 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.